HP eNews Update May 2017

AMS
www.menopause.org.au 2017
---
HP eNews

Welcome to AMS HP eNews for doctors and other healthcare professionals who have a special interest in women's health. The content covers information and resources relevant to menopause, midlife and the promotion of healthy ageing.
 

In this edition

 

May 2017

21st AMS Congress 2017

AMS Congress 2017 

The members of your local organising committee are delighted to invite you to attend the 21st Congress of the Australasian Menopause Society.

This year's congress will be held at the Sofitel Sydney Wentworth from Friday 13th to Sunday 15th of October. It promises to be a ripper!

Registration

Registration for AMS 2017 is now open. For more information, please visit the conference website www.ams2017.org/registration.

Program

The preliminary program is available online, please click here www.ams2017.org/program to view.

Abstracts

Abstract submissions are now open, please click here www.ams2017.org/abstracts to submit and view abstract guidelines.

We look forward to seeing you at the Congress in October

Kind regards,

Sheila O’Neill
For The 2017 Organising Committee

readmore

 

 

Menopause Essentials Update  

menopause essentials 2017This popular series continues in Brisbane in association with the 43rd ASPOG Scientific Meeting. The workshop is aimed at all GPs, specialists and allied health workers who are seeking a comprehensive update in the field of menopause. 

Drs Georgina Hale and Jane Elliott will be presenting on the following:

  • Menopause and how to approach it
  • How to prescribe MHT
  • Non-hormonal treatments for menopausal symptoms, and sexual dysfunction
  • Case studies 

Venue
Park Regis North Quay, Brisbane 

Registration
$50 for AMS Members, $75 for Non­‐members

https://meetingpeople.eventsair.com/aspog-2017/meuregonly  

readmore

 

 

AMS in the Media

Oestrogen patch shortage information

Fairfax through The Sydney Morning Herald and The Age, has published a story about the current shortage of oestrogen patches, a hormone replacement treatment used to manage menopausal symptoms.

With so many questions being raised about the shortage, Jean Hailes Medical Director Dr Elizabeth Farrell AO and Jean Hailes endocrinologist and AMS Board Member Dr Sonia Davison, have answered three pertinent questions.

  • If I use oestrogen patches such as Estradot (oestrogen only) and Estalis (combined oestrogen and progestogen), what does the shortage mean for me?
  • How do I decide what alternative HRT I should use?
  • When are supplies expected to return to normal?

For the answers see here

Menopause is surrounded by unhealthy information

In this article in Sydney Morning Herald Jen Vuk discusses why so many women are dismissive of menopausal hormone therapy (MHT) [also known as hormone replacement therapy HRT].

The article briefly reviews the Women's Health Initiative (WHI) study initially released in 2002 which greatly impacted use of MHT. 

The auther cites Professor R D Langer's article The evidence base for HRT: what can we believe?

For more see here

Everything you need to know about menopause: Because it's whole lot more than hot flushes

For the article the AMS President Professor Bronwyn Stuckey, Endocrinologist and medical director of WA's Keogh Institute for Medical Research; Sydney-based GP Dr Ginni Mansberg; and Professor John Eden, Director of the Women's Health and Research Institute of Australia were interviewed. 

All three doctors said that women:

should consider Hormone Replacement Therapy to treat post-menopause symptoms, despite beliefs that HRT is linked to breast cancer, thanks to a 2002 study by the Women's Health Institute.

For more see here.

I still want to have sex but my body doesn't respond

In this article about female sexual dysfunction Maureen Matthews has spoken with:

Dr Sonia Davison, endocrinologist at Jean Hailes for Women's Health and AMS Director:

"There is no one correct answer or approach to female sexual dysfunction and it is useful to consult with an expert in this area, who may be a sexual counsellor or a dedicated women's health practitioner. Further information can be found at jeanhailes.org.au/health-a-z/sex-sexual-health or at the Australasian Menopause Society webpage, "Sexual difficulties in the Menopause".

Dr Anita Elias is the head of Monash Health's Sexual Medicine and Therapy Clinic, and Sexual Counselling Clinic at the Royal Women's Hospital's Malvern Psychotherapy Centre

"As we get older, both women and men need more or different stimulation (physical, mental and emotional) to achieve the same level of pleasure and arousal".

For more see here.  

readmore

 

 

Join AMS for Member's only content

See exclusive commentary on studies such as:

The endometrial and breast safety of menopausal hormone therapy containing micronised progesterone: A short review.

For a significant minority of women, menopausal symptoms can be very unpleasant; however, many are worried about taking menopausal hormone therapy (MHT) for fear of causing breast cancer. Micronised progesterone (mP4) has been available in Europe since the 1990s and clinical trials have shown that 100 mg oral daily, 200 mg oral sequentially or 100 mg vaginal every 2nd day effectively protect the endometrium from the stimulatory effects of estrogen. MHT containing mP4 has a significantly lower breast cancer risk than those containing progestins. Micronised progesterone does not appear to attenuate the cardiovascular benefits of estrogen. Pharmaceutical grade, body identical MHT is now available in Australia. 

Neurokinin-3 receptor antagonist to treat hot flushes 

Hot flushes, which are among the most frequent symptoms of menopause, are considered to be the result of the changes in the sex hormone milieu and tissue exposure at midlife and beyond. However, modern medicine tries also to tie physiological processes with the individual gene profile. This was also done in regard to vasomotor symptoms (VMS) in the WHI study, in search of potential associations between VMS and certain genetic variations and single nucleotide polymorphisms (SNPs). 

Join the AMS now

Upcoming Conferences

11th Congress of the European Menopause and Andropause Society (EMAS)
Amsterdam, Holland
22-24 May 2017
www.emas-online.org/home2017 

25th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI)
Vienna, Austria
November 30 - December 2, 2017
www.cogi-congress.org  readmore


---
AMS Congress 2017
---
Copyright © 2017
Australasian Menopause Society Ltd.
PO Box 511, Inverloch VIC 3996
Tel: +61 3 9428 8738 | Email: ams@menopause.org.au
Join the AMS now
Contact us |